Breaking News
Get Actionable Insights with InvestingPro+: Start 7 Day FREE Trial Register here
Investing Pro 0
Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% More details
Close

GlaxoSmithKline PLC (GSK)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
2,477.00 +27.00    +1.10%
20/01 - Closed. Currency in ARS ( Disclaimer )
  • Volume: 58
  • Bid/Ask: 2,477.00 / 2,478.50
  • Day's Range: 2,431.00 - 2,473.00
Type:  Equity
Market:  Argentina
ISIN:  ARDEUT110483 
GlaxoSmithKline 2,477.00 +27.00 +1.10%
Period Ending: 2021
30/09
2021
30/06
2021
31/03
2020
31/12
Total Revenue 9077 8092 7418 8739
Revenue 9077 8092 7418 8739
Other Revenue, Total - - - -
Cost of Revenue, Total 2822 2519 2411 2962
Gross Profit 6255 5573 5007 5777
Total Operating Expenses 7139 6417 5725 7678
Selling/General/Admin. Expenses, Total 2504 2498 2315 2924
Research & Development 1169 1165 1077 1297
Depreciation / Amortization 25 25 26 26
Interest Expense (Income) - Net Operating - - - -
Unusual Expense (Income) 735 287 -13 560
Other Operating Expenses, Total -116 -77 -91 -91
Operating Income 1938 1675 1693 1061
Interest Income (Expense), Net Non-Operating -190 -169 -175 -240
Gain (Loss) on Sale of Assets - -36 - -
Other, Net - - - -
Net Income Before Taxes 1748 1470 1518 821
Provision for Income Taxes 380 -68 258 -18
Net Income After Taxes 1368 1538 1260 839
Minority Interest -200 -143 -187 -162
Equity In Affiliates - - - -
U.S GAAP Adjustment - - - -
Net Income Before Extraordinary Items 1168 1395 1073 677
Total Extraordinary Items - - - -
Net Income 1168 1395 1073 677
Total Adjustments to Net Income - - - -
Income Available to Common Excluding Extraordinary Items 1168 1395 1073 677
Dilution Adjustment - - - -
Diluted Net Income 1168 1395 1073 677
Diluted Weighted Average Shares 5060 5060 5037 5050
Diluted EPS Excluding Extraordinary Items 0.23 0.28 0.21 0.13
DPS - Common Stock Primary Issue 0.19 0.19 0.19 0.23
Diluted Normalized EPS 0.34 0.25 0.2 0.2
* In Millions of GBP (except for per share items)
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

GSK Comments

Write your thoughts about GlaxoSmithKline PLC
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
or
Sign up with Email